Unveiling the Dual Benefits of Bosentan in Systemic Sclerosis: Risk and Relief

M.R. Lammi, MD, Johns Hopkins University School of Medicine Divisions of Pulmonary and Critical Care Medicine, Baltimore.
M. Mukherjee, MD, MPH, Johns Hopkins University School of Medicine Divisions of Pulmonary and Critical Care Medicine, and Division of Cardiology, Baltimore, Maryland, USA.

FUNDING: The authors receive funding from the National Scleroderma Foundation (MRL, MM), National Institutes of Health/ National Heart, Lung, and Blood Institute R01HL162851 (MM), US Department of Defense (MRL, MM).
COMPETING INTERESTS: The authors declare no conflicts of interest relevant to this article.

Address correspondence to Dr. M. Mukherjee, Johns Hopkins University School of Medicine, 301 Mason Lord Drive, Suite 2400, Baltimore, MD 21224, USA. Email: mmukher2@jhu.edu.